<DOC>
	<DOCNO>NCT00630851</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Aricept nursing home patient severe Alzheimer 's disease .</brief_summary>
	<brief_title>A Study Efficacy Safety Aricept Patients With Severe Alzheimer 's Disease Who Are Living Skilled Nursing Homes</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Probable possible Alzheimer 's disease Living skilled nursing home Other type dementia psychiatric neurologic disorder Musculoskeletal disease</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>